Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2022-01-21 00:00:00 ET · period of report 2022-01-21 · accession 0001209191-22-004460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-21 | XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Off | P - Purchase | $28.81 | +700 | 700 | New | +$20.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-01-21 | P | A | 700 | $28.81 | 700 | D | — | — |